Gevo, Inc. (GEVO) stock
GEVONasdaqIndustrial Organic ChemicalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3032% below fair value
$1.64−0.10 (-5.75%)
Close on Nov 17, 2026Market cap $405.47MP/E –Yield –
Gevo r&d expenses
Research and development expenses are spending on new products and technology.
Gevo's R&D Expenses for the twelve months ending Jun 30, 2026 was $4.50M, up 3.0% year over year. For fiscal 2025 it was $4.55M, down 18.4% from the year before. Over ten years it grew -3.7% a year on average. The highest annual figure on record is $20.18M in fiscal 2013.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.55M | -18.4% |
| FY2024 | Dec 31, 2024 | $5.58M | -16.0% |
| FY2023 | Dec 31, 2023 | $6.64M | -10.6% |
| FY2022 | Dec 31, 2022 | $7.43M | +9.6% |
| FY2021 | Dec 31, 2021 | $6.78M | +93.0% |
| FY2020 | Dec 31, 2020 | $3.51M | -9.2% |
| FY2019 | Dec 31, 2019 | $3.87M | -28.0% |
| FY2018 | Dec 31, 2018 | $5.37M | +3.7% |
| FY2017 | Dec 31, 2017 | $5.18M | -0.7% |
| FY2016 | Dec 31, 2016 | $5.22M | -21.1% |
| FY2015 | Dec 31, 2015 | $6.61M | -53.2% |
| FY2014 | Dec 31, 2014 | $14.12M | -30.0% |
| FY2013 | Dec 31, 2013 | $20.18M | +3.8% |
| FY2012 | Dec 31, 2012 | $19.43M | -1.6% |
| FY2011 | Dec 31, 2011 | $19.75M | +33.3% |
| FY2010 | Dec 31, 2010 | $14.82M | +41.0% |
| FY2009 | Dec 31, 2009 | $10.51M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $440.00K | -52.9% |
| Q1 FY2026 | Mar 31, 2026 | $1.50M | +42.5% |
| Q4 FY2025 | Dec 31, 2025 | $1.29M | +1.3% |
| Q3 FY2025 | Sep 30, 2025 | $1.27M | +14.4% |
| Q2 FY2025 | Jun 30, 2025 | $934.00K | -43.1% |
| Q1 FY2025 | Mar 31, 2025 | $1.05M | -32.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.27M | -33.7% |
| Q3 FY2024 | Sep 30, 2024 | $1.11M | -28.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.64M | -16.3% |
| Q1 FY2024 | Mar 31, 2024 | $1.55M | +29.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.92M | -29.0% |
| Q3 FY2023 | Sep 30, 2023 | $1.56M | -0.3% |
| Q2 FY2023 | Jun 30, 2023 | $1.96M | -0.3% |
| Q1 FY2023 | Mar 31, 2023 | $1.20M | +0.5% |
| Q4 FY2022 | Dec 31, 2022 | $2.71M | +5.3% |
| Q3 FY2022 | Sep 30, 2022 | $1.56M | +4.5% |
| Q2 FY2022 | Jun 30, 2022 | $1.97M | +47.6% |
| Q1 FY2022 | Mar 31, 2022 | $1.19M | -13.5% |
| Q4 FY2021 | Dec 31, 2021 | $2.57M | +85.7% |
| Q3 FY2021 | Sep 30, 2021 | $1.50M | +71.8% |
| Q2 FY2021 | Jun 30, 2021 | $1.33M | +96.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.38M | +137.6% |
| Q4 FY2020 | Dec 31, 2020 | $1.38M | +787.2% |
| Q3 FY2020 | Sep 30, 2020 | $870.00K | -51.4% |
| Q2 FY2020 | Jun 30, 2020 | $677.00K | -28.4% |
| Q1 FY2020 | Mar 31, 2020 | $580.00K | -40.7% |
| Q4 FY2019 | Dec 31, 2019 | $156.00K | -87.5% |
| Q3 FY2019 | Sep 30, 2019 | $1.79M | -4.1% |
| Q2 FY2019 | Jun 30, 2019 | $945.00K | -35.7% |
| Q1 FY2019 | Mar 31, 2019 | $978.00K | +24.0% |
| Q4 FY2018 | Dec 31, 2018 | $1.25M | +44.8% |
| Q3 FY2018 | Sep 30, 2018 | $1.87M | +54.1% |
| Q2 FY2018 | Jun 30, 2018 | $1.47M | -22.3% |
| Q1 FY2018 | Mar 31, 2018 | $789.00K | -35.2% |
| Q4 FY2017 | Dec 31, 2017 | $864.00K | -44.1% |
| Q3 FY2017 | Sep 30, 2017 | $1.21M | +4.7% |
| Q2 FY2017 | Jun 30, 2017 | $1.89M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.22M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.55M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.16M | – |
See a number that looks wrong?